Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1952 8
1953 37
1954 27
1955 34
1956 72
1957 75
1958 98
1959 98
1960 97
1961 94
1962 148
1963 208
1964 265
1965 179
1966 207
1967 237
1968 223
1969 272
1970 271
1971 275
1972 365
1973 411
1974 472
1975 503
1976 523
1977 592
1978 683
1979 686
1980 743
1981 711
1982 721
1983 755
1984 784
1985 793
1986 828
1987 785
1988 749
1989 789
1990 783
1991 756
1992 681
1993 674
1994 662
1995 587
1996 623
1997 636
1998 556
1999 520
2000 515
2001 534
2002 504
2003 545
2004 495
2005 619
2006 539
2007 565
2008 566
2009 590
2010 591
2011 591
2012 588
2013 647
2014 611
2015 629
2016 662
2017 656
2018 651
2019 655
2020 746
2021 837
2022 790
2023 681
2024 238

Text availability

Article attribute

Article type

Publication date

Search Results

34,618 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine.
Escobar-Morreale HF, Botella-Carretero JI, Morreale de Escobar G. Escobar-Morreale HF, et al. Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):57-75. doi: 10.1016/j.beem.2014.10.004. Epub 2014 Oct 25. Best Pract Res Clin Endocrinol Metab. 2015. PMID: 25617173 Review.
At present, the drug of choice for the treatment of hypothyroidism is levothyroxine sodium, even though the thyroid gland secretes both thyroxine and 3',3,5-triiodothyronine; the latter is the more active of the two at the cellular level because of its higher affinity for …
At present, the drug of choice for the treatment of hypothyroidism is levothyroxine sodium, even though the thyroid gland secretes both thyr …
Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
Van Tassell B, Wohlford GF 4th, Linderman JD, Smith S, Yavuz S, Pucino F, Celi FS. Van Tassell B, et al. Thyroid. 2019 Oct;29(10):1371-1379. doi: 10.1089/thy.2019.0101. Epub 2019 Sep 12. Thyroid. 2019. PMID: 31364488 Free PMC article. Clinical Trial.
Background: L-triiodothyronine (LT3) is a substitute for levothyroxine (LT4) for thyroid cancer (TC) patients during the preparation for nuclear medicine procedures, and it is used in combination with LT4 in patients who do not respond to the standard treatment for …
Background: L-triiodothyronine (LT3) is a substitute for levothyroxine (LT4) for thyroid cancer (TC) patients during the prepa …
Triiodothyronine.
Hoffenberg R. Hoffenberg R. Clin Endocrinol (Oxf). 1973 Jan;2(1):75-87. doi: 10.1111/j.1365-2265.1973.tb03487.x. Clin Endocrinol (Oxf). 1973. PMID: 4588947 Review. No abstract available.
Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism.
Fadeyev VV, Morgunova TB, Melnichenko GA, Dedov II. Fadeyev VV, et al. Hormones (Athens). 2010 Jul-Sep;9(3):245-52. doi: 10.14310/horm.2002.1274. Hormones (Athens). 2010. PMID: 20688622 Free article. Clinical Trial.
OBJECTIVE: The objective of this study was to compare various parameters in patients with hypothyroidism receiving either monotherapy with L-thyroxine (L-T4) or combination therapy with L-T4 and L-triiodothyronine (L-T3). DESIGN: We conducted a randomized, controlle …
OBJECTIVE: The objective of this study was to compare various parameters in patients with hypothyroidism receiving either monotherapy with L …
L-triiodothyronine: is this peripheral hormone a central neurotransmitter?
Mason GA, Walker CH, Prange AJ Jr. Mason GA, et al. Neuropsychopharmacology. 1993 May;8(3):253-8. doi: 10.1038/npp.1993.28. Neuropsychopharmacology. 1993. PMID: 8099484
L-triiodothyronine (T3) has previously been shown to enhance fast-phase, depolarization-induced 45Ca uptake and 3H-gamma-aminobutyric acid release by rat brain synaptosomes at low nanomolar concentrations comparable to those reported for whole brain. ...
L-triiodothyronine (T3) has previously been shown to enhance fast-phase, depolarization-induced 45Ca uptake and 3H-gamma-amino …
Alternative ligands for thyroid hormone receptors.
Lazcano I, Hernández-Puga G, Robles JP, Orozco A. Lazcano I, et al. Mol Cell Endocrinol. 2019 Aug 1;493:110448. doi: 10.1016/j.mce.2019.05.007. Epub 2019 May 14. Mol Cell Endocrinol. 2019. PMID: 31100496 Review.
Thyroid hormone receptors (TRs) are ligand-dependent transcription factors that activate or repress gene transcription, resulting in the regulation of numerous physiological programs. While 3,3',5-L-triiodothyronine is the TR cognate ligand, these receptors can also …
Thyroid hormone receptors (TRs) are ligand-dependent transcription factors that activate or repress gene transcription, resulting in the reg …
Effect of 3:5:3'-L-triiodothyronine in myxoedema.
GROSS J, PITT-RIVERS R, TROTTER WR. GROSS J, et al. Lancet. 1952 May 24;1(6717):1044-5. doi: 10.1016/s0140-6736(52)90695-8. Lancet. 1952. PMID: 14928556 No abstract available.
34,618 results
You have reached the last available page of results. Please see the User Guide for more information.